Mechanism and prospects of mitochondrial transplantation for spinal cord injury treatment
Authors:
Open Access
- 28 November 2024
- journal article
- review article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-9
Abstract
Spinal cord injury (SCI) involves a continuous and dynamic cascade of complex reactions, with mitochondrial damage and dysfunction-induced energy metabolism disorders playing a central role throughout the process. These disorders not only determine the severity of secondary injuries but also influence the potential for axonal regeneration. Given the critical role of energy metabolism disturbances in the pathology of SCI, strategies such as enhancing mitochondrial transport within axons to alleviate local energy deficits, or transplanting autologous or allogeneic mitochondria to restore energy supply to damaged tissues, have emerged as potential approaches for SCI repair. These strategies also aim to modulate local inflammatory responses and apoptosis. Preclinical studies have initially demonstrated that mitochondrial transplantation (MT) significantly reduces neuronal death and promotes axonal regeneration following spinal cord injury. MT achieves this by regulating signaling pathways such as MAPK/ERK and PI3K/Akt, promoting the expression of growth-associated protein-43 (GAP-43) in neurons, and inhibiting the expression of apoptosis-related proteins like Grp78, Chop, and P-Akt, thereby enhancing the survival and regeneration of damaged neurons. Additionally, MT plays a role in promoting the expression of vascular endothelial growth factor, facilitating tissue repair, and reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Furthermore, MT modulates neuronal apoptosis and inflammatory responses by decreasing the expression of p-JNK, a member of the MAPK family. In summary, by reviewing the detailed mechanisms underlying the cascade of pathological processes in SCI, we emphasize the changes in endogenous mitochondria post-SCI and the potential of exogenous MT in SCI repair. This review aims to provide insights and a basis for developing more effective clinical treatments for SCI.Keywords
This publication has 60 references indexed in Scilit:
- Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 2013
- Assembly of a new growth cone after axotomy: the precursor to axon regenerationNature Reviews Neuroscience, 2012
- Injection of isolated mitochondria during early reperfusion for cardioprotectionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Docking of Axonal Mitochondria by Syntaphilin Controls Their Mobility and Affects Short-Term FacilitationCell, 2008
- Mitochondrial Transporters as Novel Targets for Intracellular Calcium SignalingPhysiological Reviews, 2007
- The role of astrocytes in the physiology and pathology of the central nervous systemActa Neurobiologiae Experimentalis, 2006
- Regional and developmental regulation of syntaphilin expression in the brain: a candidate molecular element of synaptic functional differentiationMolecular Brain Research, 2003
- Macrophages and Microglia in Central Nervous System Injury: Are They Helpful or Harmful?Journal of Cerebral Blood Flow & Metabolism, 2003
- Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous SystemPhysiological Reviews, 2001
- Calcium metabolism of focal and penumbral tissues in rats subjected to transient middle cerebral artery occlusionExperimental Brain Research, 1998